Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis for lipid nutrient differences in the milk of 13 species from a quantitative non-targeted lipidomics perspective. | Food Chem X | 2023 | 38144754 | PubTator, text mining | PubMed |
| Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer. | Biology (Basel) | 2023 | 38132318 | PubTator, text mining | PubMed |
| Haploid-genetic screening of trophectoderm specification identifies Dyrk1a as a repressor of totipotent-like status. | Sci Adv | 2023 | 38117886 | PubTator, text mining | PubMed |
| Analysis of SARS-CoV-2 Variant-Specific Serum Antibody Post-Vaccination Utilizing Immortalized Human Hepatocyte-Like Cells (HLC) to Assess Development of Immunity. | Hepat Med | 2023 | 38078048 | PubTator, text mining | PubMed |
| Increased Hepatocyte Growth Factor Secretion by Placenta-Derived Mesenchymal Stem Cells Improves Ovarian Function in an Ovariectomized Rat Model via Vascular Remodeling by Wnt Signaling Activation. | Cells | 2023 | 38067136 | PubTator, text mining | PubMed |
| Cross-kingdom regulation by plant-derived miRNAs in mammalian systems. | Animal Model Exp Med | 2023 | 38064180 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. | J Hematol Oncol | 2023 | 38037103 | PubTator, text mining | PubMed |
| Exploring maternal-fetal interface with in vitro placental and trophoblastic models. | Front Cell Dev Biol | 2023 | 38033854 | PubTator, text mining | PubMed |
| The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. | Glob Med Genet | 2023 | 38025193 | PubTator, text mining | PubMed |
| Generation of Mouse Primitive Endoderm Stem Cells. | Bio Protoc | 2023 | 38023790 | PubTator, text mining | PubMed |
| Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging. | Clin Cosmet Investig Dermatol | 2023 | 38021432 | PubTator, text mining | PubMed |
| In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced. | J Pers Med | 2023 | 38003890 | PubTator, text mining | PubMed |
| Increased IGFBP2 Levels by Placenta-Derived Mesenchymal Stem Cells Enhance Glucose Metabolism in a TAA-Injured Rat Model via AMPK Signaling Pathway. | Int J Mol Sci | 2023 | 38003735 | PubTator, text mining | PubMed |
| Potential of dental pulp stem cells and their products in promoting peripheral nerve regeneration and their future applications. | World J Stem Cells | 2023 | 37970238 | PubTator, text mining | PubMed |
| Effects of green light-emitting diode irradiation on hepatic differentiation of hepatocyte-like cells generated from human adipose-derived mesenchymal cells. | Sci Rep | 2023 | 37968291 | PubTator, text mining | PubMed |
| Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. | JID Innov | 2023 | 37965425 | PubTator, text mining | PubMed |
| Histatin 1-modified SIS hydrogels enhance the sealing of peri-implant mucosa to prevent peri-implantitis. | iScience | 2023 | 37965149 | PubTator, text mining | PubMed |
| Addressing Key Questions in Organoid Models: Who, Where, How, and Why? | Int J Mol Sci | 2023 | 37958996 | PubTator, text mining | PubMed |
| Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy Model. | Int J Mol Sci | 2023 | 37958895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=8